AI assistant
Linde PLC — Director's Dealing 2023
Feb 15, 2023
9953_dirs_2023-02-15_9f3e1323-9c6c-41c1-a3f1-99610cfebfd6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LINDE PLC (LIN)
CIK: 0001707925
Period of Report: 2023-02-13
Reporting Person: Lamba Sanjiv (Director, Chief Executive Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-02-13 | Deferred Stock Units | $143.57 | A | 143.57 | Acquired | Ordinary Shares (143.57) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 47084 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Units | $ | Ordinary Shares (6335) | 6335 | Direct | |
| Restricted Stock Units | $ | Ordinary Shares (3895) | 3895 | Direct | |
| Restricted Stock Units | $ | Ordinary Shares (3090) | 3090 | Direct | |
| Stock Options (right to buy) | $270.99 | 2032-03-07 | Ordinary Shares (54920) | 54920 | Direct |
| Stock Option (right to buy) | $253.68 | 2031-03-08 | Ordinary Shares (40995) | 40995 | Direct |
| Stock Option (right to buy) | $173.13 | 2030-03-09 | Ordinary Shares (37565) | 37565 | Direct |
| Stock Option (right to buy) | $176.63 | 2029-03-20 | Ordinary Shares (40470) | 40470 | Direct |
Footnotes
F1: Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis.
F2: Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis.
F3: Restricted Stock Units that will vest in full and payout on or about March 9, 2023 in Linde plc Ordinary Shares on a one-for-one basis.
F4: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
F5: This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.
F6: This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.
F7: Stock options have been granted pursuant to the Business Combination Agreement among Praxair, Inc., Linde AG, Linde plc and certain of their affiliates, dated June 1, 2017, as amended (the "BCA"). The stock options replace certain previously granted equity awards granted by Linde AG that were terminated in connection with the closing of the Business Combination of Praxair, Inc. and Linde AG that occurred on October 31, 2018. A more detailed explanation of these stock option replacement awards is discussed in the Linde plc Registration Statement on Form S-4 (Amendment No. 4) filed with the SEC on August 11, 2017 under the section titled "The Business Combination - Interests of Directors, Board Members and Executive Officers in the Business Combination - Linde AG - Treatment of Equity Awards" on pages 183-187.
F8: Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.
F9: Deferred Stock Units acquired under the Linde Compensation Deferral Plan that will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Deferral Plan.